Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
84.15m
Last Price
$2.51
52-Week Range
$2.44 - $5.4566
06/03/2026 04:49 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808